CAR-T in Relapsed/Refractory Multiple Myeloma
1d agoen
From the article
Conditions : Multiple Myeloma Refractory; Multiple Myeloma in Relapse Interventions : Biological: CAR-T Sponsors : Dr. Zaineb Akram Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Resetting autoimmune disease with CAR cell therapies
doi.org·14d ago

Donor-derived stem cell memory CAR T cells show enhanced expansion and safety in post-HSCT relapse treatment
This first-in-human study (NCT01087294) investigates donor-derived CD19-CAR T cells for treating B cell malignancies relapsing after allogen
cell.com·8d ago
CAR T-cell therapy bolstered by stiffening up cancer cells first
newscientist.com·1mo ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·13d ago

OHSU logra un gran avance en la ciencia médica con las terapias celulares
Oregon Health & Sciences University·12d ago

Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an
cell.com·12d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.